Covid-19 Information & Useful websites
Reproduction number Update Minister for Health Stephen Donnelly
IRELAND’S R NUMBER has fallen to between 0.7 and 1.4 with the “best estimate” standing at 1.1, Health Minister Stephen Donnelly has said. Donnelly also said public health officials are saying “we are going to have a second surge” of Covid-19 based on evidence from around the world. It was reported last week that the country’s R number had risen from below 1 to between 1.2 and 1.8. Donnelly today described that as a “serious concern to public health and to the wider community”. The R number is the rate at which the disease spreads from an infected person to other people – so if the R-number is at 1, an infected person will spread it to an average of one other person. The minister said the “best estimate” for the current R number in Ireland is 1.1 based on figures presented to him earlier today
Dail Eireann Statement from the Minister of Health Stephen Donnelly
HSE Staff Webinar COVID-19 Q&A Session with CEO Paul Reid, Chief Operations Officer (COO) Anne O’Connor and Chief Clinical Officer (CCO) Colm Henry
Discussions included the balancing of services if what needed to be stopped and what needed to keep going The HSE have been reviewing all the work streams in the case of a second wave , to be prepared and equipped. The HSE will retain the Covid response teams in the communities to support the nursing teams Community testing will continue . Working in an integrated work between national and local systems to empower them . One of the big areas of focus is care of the elderly to keep them at home and avoid long term care homes . The team emphasised again that all health care staff should avail of the flu vaccination. Framework launched in June for the restoration of services . Activities will be slower to ensure infection prevention guidelines are compiled too. A roadmap to service restoration was launched today 22nd July . The Cervical backlog will be cleared by October . Cancer services lancet pathways to cancer. Early access to cancer services through screening There was a fall off to rapid access clinics by 50 % .Earlier diagnosis enhances better treatment outcomes .
How can we support exhausted staff who have worked relentlessly since Jan ? Encourage staff to take their annual leave now . Local systems are facilitating flexible working arrangements . Continuing to recruit extra staff . Now an additional 3,5500 staff on the payroll . Staff need to be resilient and prepared for the winter . Click Here:
Recovery from Covid-19
It’s common to have health symptoms or side effects after having coronavirus (COVID-19).Some people have physical problems such as extreme tiredness (fatigue) or muscle pain. Others can experience mood changes or nightmares. Some people have no symptoms or side effects at all. Symptoms or side effects can depend on how mild or severe your illness from coronavirus was. It can also depend on if you were in hospital or not. Getting back to normal after coronavirus can take some people a few months. But things usually improve over time.
Physical problems after coronavirus
Physical problems you might experience while recovering from coronavirus include:
- muscle weakness and joint stiffness
- extreme tiredness (fatigue) and a lack of energy
- reduced mobility
- breathlessness – read a guide on managing breathlessness
- phlegm build-up – read how to clear phlegm from your lungs
- weaker physical fitness
- loss of appetite and weight loss
- lack of sense of smell or taste
- stomach problems – this includes heartburn, diarrhoea and vomiting
- difficulties swallowing – read advice on how to manage this
Mental and emotional problems after coronavirus
Mental and emotional problems you might experience while recovering from coronavirus include:
- sleep problems – this can often develop after being in hospital, where it can be difficult to sleep
- problems with mental abilities – for example, not being able to remember some events, think clearly and being forgetful
- changes in your mood, or depression or anxiety
- nightmares or flashbacks
- post-traumatic stress disorder (PTSD)
- confusion or delirium
Read advice on minding your mental health during the coronavirus pandemic
When to get medical help
Phone your GP or hospital team if you find it difficult to cope with your symptoms. They will give you the support you need and direct you to services. Many mental health services and organisations provide free online and phone services.
Suffering a severe illness and spending time in hospital can be extremely stressful. Some people recover from coronavirus quickly and do not need much support. Other people will need more time and help. Your recovery time could depend on the level of treatment you got in hospital. It can take months to fully recover. Everyone is different. It’s important not to compare yourself to others. Having good and bad days during your recovery is normal. It’s OK to feel this way. Things that might help you to feel a bit better in your recovery include:
- talk to family, friends or your GP
- do things you enjoy
- rest and relax – meditation or mindfulness may help
- be kind to yourself
Free Printable Covid-19 Poster
As we battle the spread of COVID-19 and understand more and more how transmission can occur from person-to-person, workspaces can quickly become outbreak sites unless the correct measures are taken. Signs are the best way to create and maintain awareness.
You can download and print all signs like the one below for free and use them as you need. If you share these images online then please link to our site.
Stay Healthy, Wash Your Hands
New Ways of Working in the care of Older People during Covid-19
This work is under review the learnings should be relevant for future health system planning’
TCD Research: Autism and Related Neurodevelopmental Disorders
COVID-19 is impacting mental health and behaviour in autistic and typically developing children. This is a global problem. Help @AutismTCD understand the problem and highlight what supports need to be in place. We need 1000 responses to represent the situation clearly and accurately.’ Please complete our 20 min survey at this link
HSE Guidance Non-Essential Travel
National Director of HR
“All employees who intend to undertake non-essential travel overseas must make provision by way of an annual leave or unpaid leave application for the additional period of restricted movement, in line with their employer’s normal rules and procedures for applying for annual leave or unpaid leave1. Employees will not be permitted to work from home in lieu of taking annual leave or unpaid leave during the 14-day period of restricted movement. Employees must advise their manager of their intention to travel abroad and submit their leave application to cover the additional period of 14 days’ absence from work due to the requirement to restrict their movements upon return to Ireland. The leave application required to cover the additional period of restricted movement must be approved by the manager prior to commencement of annual leave/travel abroad and a record retained. Employees are required to give as much notice as possible of their intention to travel abroad so that the necessary arrangements (e.g. substitution cover) can be made to cover the employee’s additional period of absence having regard to service requirements. The requirement that health service employees inform their manager of plans to travel abroad and adhere to the requirement to restrict their movements for 14 days upon return to Ireland is necessary for the protection of public health and for service planning. This guidance will be reviewed in accordance with any changes to public health and travel advice”
In line with the Government’s Return to Work Safely Protocol, we are issuing our OSH Newsletter to support you in the resumption of services safely.
In this issue you will find:
- Information on the COVID-19 Induction training
- Information on the Return to Work Safely process
- Sample risk assessment to include requirements for COVID-19
- New safety training available on hseland
Irish Medical times
Free Covid-19 Asthma Health Packs made available :
The packs contain information and support to help asthmatics stay safe during this Covid-19 pandemic
The Asthma Society of Ireland has partnered with Care Plus Pharmacy to supply free Covid-19 health packs to people with asthma in Ireland.
This Covid-19 Health Pack initiative is only the first step in a new partnership between Care Plus and the Asthma Society. People with asthma and their families and friends can pick up Covid-19 Asthma Health Packs for free from the 64 Care Plus pharmacies nationwide. The packs contain information and support to help people stay safe during this Covid-19 pandemic. The resources within these packs were put together with the assistance of members of the Asthma Society’s Medical Advisory Group. They draw on expertise from the Health Service Executive (HSE) and the National Respiratory Clinical Programme, including some of the top respiratory healthcare professionals in the country. These packs consist of patient education materials on asthma or chronic obstructive pulmonary disease and Covid-19, as well as information on general asthma management, dealing with an asthma attack by the 5 Step Rule, gardening with asthma and hay fever, and details of key services offered by the Asthma Society during this pandemic. Care Plus pharmacists will be on hand to help asthma patients with advice on asthma management and to address their concerns. The packs contain information and support to help asthmatics stay safe during this Covid-19 pandemic. The Asthma Society of Ireland has partnered with Care Plus Pharmacy to supply free Covid-19 health packs to people with asthma in Ireland. This Covid-19 Health Pack initiative is only the first step in a new partnership between Care Plus and the Asthma Society. People with asthma and their families and friends can pick up Covid-19 Asthma Health Packs for free from the 64 Care Plus pharmacies nationwide. The packs contain information and support to help people stay safe during this Covid-19 pandemic. The resources within these packs were put together with the assistance of members of the Asthma Society’s Medical Advisory Group. They draw on expertise from the Health Service Executive (HSE) and the National Respiratory Clinical Programme, including some of the top respiratory healthcare professionals in the country. These packs consist of patient education materials on asthma or chronic obstructive pulmonary disease and Covid-19, as well as information on general asthma management, dealing with an asthma attack by the 5 Step Rule, gardening with asthma and hay fever, and details of key services offered by the Asthma Society during this pandemic. Care Plus pharmacists will be on hand to help asthma patients with advice on asthma management and to address their concerns.
COVID-19 Return to Work Safely webinar
The National Health and Safety Function (NHSF), working in collaboration with HSE Estates, have developed a second module in its COVID-19 Return to Work Safely webinar series. The pre-recorded webinar has been developed to provide managers with information on the HSE’s approach to implementing the Government’s Return to Work Safely Protocol in all HSE workplaces.
Returning to Work Safely Webinar – Module 2 is mandatory for all HSE Line Managers and those who are responsible for, or support the implementation of, health and safety locally.
Presented by Nick Parkinson, Head of National Health and Safety Function and Deirdre Groarke, Estates Manager – Safety and Infrastructural Risk, the webinar covers the following topics:
- Employer and Employee Responsibilities related to COVID-19
- How the Return to Work Safely (RWS) Protocol applies to the HSE
- COVID-19 Induction Programme
- Key actions required to ensure a safe return to the workplace
- Guidance, templates, and forms to aid the safe return to work
- Further supports available
The module will take approximately 40 minutes to complete and a certificate is issued upon completion.
To access and complete this eLearning module, search for Returning to Work Safely Webinar – Module 2 or access the webinar resource in the HSE National Health and Safety Function Learning Catalogue. Click Here:
Covid-19 Tracker App
Stay safe. Protect each other.
COVID Tracker is a free app for your mobile phone. It will help us to protect each other and slow the spread of coronavirus (COVID-19) in Ireland.
Using the COVID Tracker app along with the existing public health measures will help us all stay safe when we meet up, socialise, work or travel.
The app can:
- alert you if you have been in close contact with someone who has tested positive for COVID-19
- advise you on what to do to protect yourself and others
- alert other app users that you were in close contact with, if you test positive for COVID-19
Follow the link below to get the app.
Covid-19 Data hub Confirmed Cases Acute Hospitals
WHO Director-General’s opening remarks at the media briefing on COVID-19 – 7 July 2020
It took 12 weeks for the world to reach 400 thousand cases of COVID-19. Over the weekend, there were more than 400 thousand cases across the globe. There have now been 11.4 million cases of COVID-19 and more than 535,000 lives have been lost. The outbreak is accelerating, and we have clearly not reached the peak of the pandemic. While the number of deaths appears to have levelled off globally, in reality some countries have made significant progress in reducing the number of deaths, while in other countries deaths are still on the rise. Where there has been progress in reducing deaths, countries have implemented targeted actions toward the most vulnerable groups, for example those people living in long-term care facilities. Over the past few months, there has been a lot of discussion about the origins of COVID-19. All preparations have been finalised and WHO experts will be traveling to China this weekend to prepare scientific plans with their Chinese counterparts for identifying the zoonotic source of the disease. The experts will develop the scope and terms of reference for a WHO-led international mission. The mission objective is to advance the understanding of animal hosts for COVID-19 and ascertain how the disease jumped between animals and humans. WHO will continue to communicate the latest scientific advances to the media and general public as we have them. In this vein, WHO continues to work with technology companies to make sure people have access to accurate health information and resources on COVID-19. Click Here:
Resources to Support Adults Living with Long-term Health Conditions during Coronavirus
People living with a long-term health condition may be more at risk of serious illness if they get coronavirus and need to take extra care to protect themselves. A number of resources have been developed by the HSE Health & Wellbeing Self-management support Co-ordinators to support people living with long-term health conditions. Click Here:
A Directory of Resources and Supports for Adults with Asthma, COPD, Diabetes, Heart Conditions and Stroke during Coronavirus. This directory signposts people living with these conditions, or caring for someone with one, to reliable information and services. It provides information on how to access these supports.
Video clips which deliver key self-management messages have been developed. Further videos are in production. Follow HSE Health & Wellbeing on Twitter @HsehealthW and please retweet. #selfmanagementsupport
- Minding Your Long- term Health Condition during Coronavirus information leaflet
Provides practical and clear information to support people to manage their long-term health condition and to stay healthy.
In addition, in partnership with Pavee Point through the Eastern Region Traveller Health Unit, the coronavirus information leaflet was adapted for travellers with long-term health conditions.
Poster 1 Minding your long-term health: Click Here:
Return to Work safety Webinar
As part of the government Return to Work Safely Protocol, all employees must receive induction training on returning to the workplace safely and the measures which must be taken to prevent the spread of COVID-19. The National Health and Safety Function have developed this short induction webinar to support your local induction process.
This webinar provides information on roles and responsibilities set out in the protocol and adopted in the HSE, public health advice on preventing the spread of COVID-19 including signs and symptoms and routes of transmission, aspects of the workplace and our work activities which may be affected, the requirement for a plan to manage suspected cases of COVID-19 in the workplace and additional resources available to support your safe return and mental health and wellbeing.
To access and complete this eLearning training programme, search for COVID-19 Return to Work Safely Induction Webinar or access the webinar resource in the HSE National Health and Safety Function Learning Catalogue.
Reproduction number increase
Professor Philip Nolan , NPHET has stated the Reproduction umber has now increase to almost 1 .
Covid -19 Incidence
The incidence over the past 14 days in Ireland is 2.9 cases per 100,000. Many of the countries that Irish holiday makers travel have much higher incidence than here .Spain is currently at 9.9 , Portugal is 47.9 Italy is 5,2 France 10.3 and UK 22.7 .WHO has warned that in the past week, over 160,000 cases have been reported each day..
Irish Times 3rd July
Phased resumption of health services
HSE COO, Anne O’Connor updates staff on the phased resumption of health services during COVID-19Anne gives details on the careful planning which is currently happening across services to ensure the safety of our staff and patients. The Return to Work Safely (RWS) Protocol is being published as part of this work and provides useful guidance for managers and staff. Click Here:
Young people testing positive cause Dr Holohan fresh concerns
Covid-19 is an infection that affects all ages and it is incumbent on all of us to take our individual responsibility seriously.” People aged under 35 years old made up 43pc of the 23 new cases confirmed by the HPSC last night. People aged between 35 and 54 accounted for another eight cases — more than a third of the total cases. “I cannot emphasise enough how important it is to remain informed, keep a two-metre distance from others, and follow the public health advice on hand washing, cough and sneeze hygiene, and on wearing face coverings,” Dr Holohan said.
Figures from the Health Protection Surveillance Centre (HSPC) show an 87pc increase in the number of clusters in private dwellings in the last week.
There were 390 outbreaks attributed to private households on June 21, compared with 728 cases a week later on June 28.
A cluster is defined as two or more people being infected with the disease in one place.
Dr Jack Lambert, a specialist in infectious diseases at the Mater Misericordiae University Hospital in Dublin, said the public needs to “get back to basics” when it comes to preventing infection.
“There is a lot of talk about bringing Covid in from other countries but there is still Covid in Ireland,” he added.
“But there are still infections among people who haven’t travelled and that continues to be a risk.”
Dr Lambert said that as soon as people let down their guard, infections will flare up again
The Health Information and Quality Authority (HIQA) Evidence summary of the immune response following infection with SARSCoV-2 or other human coronaviruses
The Health Information and Quality Authority (HIQA) has developed a series of ‘Evidence Summaries’ to assist the Clinical Expert Advisory Group (EAG) in supporting the National Public Health Emergency Team (NPHET) in their response to COVID-19. These summaries are based on specific research questions. This evidence summary was developed to address the following research question:
What is the rate of reinfection/duration of immunity in individuals who recover from a laboratory-confirmed coronavirus infection?
Link to HIQA Evidence Summary Click Here:
European Centre for Disease Prevention and Control
Immune responses and immunity to SARS-CoV-2
The detection of antibodies to SARS-CoV-2 does not indicate directly protective immunity and correlates of protection for COVID-19 have not yet been established.
Most persons infected with SARS-CoV-2 display an antibody response between day 10 and day 21 after infection. Detection in mild cases can take longer time (four weeks or more) and in a small number of cases antibodies (i.e., IgM, IgG) are not detected at all (at least during the studies’ time scale). Based on the currently available data, the IgM and IgG antibodies to SARS-CoV-2 develop between 6–15 days post disease onset [239-244]. The median seroconversion time for total antibodies, IgM and then IgG were day-11, day-12, and day-14 post symptom onset, respectively. The presence of antibodies was detected in <40% among patients within 1 week from onset, and rapidly increased to 100% (total antibodies), 94.3% (IgM) and 79.8% (IgG) from day-15 after onset .
The longevity of the antibody response is still unknown, but it is known that antibodies to other coronaviruses wane over time (range: 12 – 52 weeks from the onset of symptoms) and homologous re-infections have been shown . SARS-CoV-2 IgM and IgG antibody levels may remain over the course of seven weeks  or at least in 80% of the cases until day 49 Click Here:
Centers for Disease Control and Prevention CDC
Development of Antibodies and Immunity
Nearly all immune competent individuals will develop an immune response following SARS-CoV-2 infection. Like infections with other pathogens, SARS-CoV-2 infection elicits development of IgM and IgG antibodies, which are the most useful for assessing antibody response because little is known about IgA response in the blood. Antibodies in some persons can be detected within the first week of illness onset. SARS-CoV-2 infections are somewhat unusual because IgM and IgG antibodies arise nearly simultaneously in serum within 2 to 3 weeks after illness onset. Thus, detection of IgM without IgG is uncommon. How long IgM and IgG antibodies remain detectable following infection is not known. In addition, development of neutralizing antibodies can also be assessed. Neutralizing antibodies inhibit viral replication in vitro, and as with many infectious diseases, their presence correlates with immunity to future infection, at least temporarily. Recurrence of COVID-19 illness appears to be very uncommon, suggesting that the presence of antibodies could confer at least short-term immunity to infection with SARS-CoV-2. Click Here:
New England Journal of Medicine
False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications
While debate has focused on the accuracy of antibody tests, which identify prior infection, diagnostic testing, which identifies current infection, has received less attention. But inaccurate diagnostic tests undermine efforts at containment of the pandemic. Diagnostic tests (typically involving a nasopharyngeal swab) can be inaccurate in two ways. A false positive result erroneously labels a person infected, with consequences including unnecessary quarantine and contact tracing. False negative results are more consequential, because infected persons — who might be asymptomatic — may not be isolated and can infect others. Given the need to know how well diagnostic tests rule out infection, it’s important to review assessment of test accuracy by the Food and Drug Administration (FDA) and clinical researchers, as well as interpretation of test results in a pandemic. The FDA has granted Emergency Use Authorizations (EUAs) to commercial test manufacturers and issued guidance on test validation.1 The agency requires measurement of analytic and clinical test performance. Analytic sensitivity indicates the likelihood that the test will be positive for material containing any virus strains and the minimum concentration the test can detect. Analytic specificity indicates the likelihood that the test will be
negative for material containing pathogens other than the target virus. Clinical evaluations, assessing performance of a test on patient specimens, vary among manufacturers. The FDA prefers the use of “natural clinical specimens” but has permitted the use of “contrived specimens” produced by adding viral RNA or inactivated virus to leftover clinical material. Ordinarily, test-performance studies entail having patients undergo an index test and a “reference standard” test determining their true state. Clinical sensitivity is the proportion of positive index tests in patients who in fact have the disease in question. Sensitivity, and its measurement, may vary with the clinical setting.Click Here:
Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
Derek K Chu, Elie A Akl, Stephanie Duda, Karla Solo, Sally Yaacoub, Holger J Schünemann
Lancet 2020 June 1
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 and is spread person-to-person through close contact. We aimed to investigate the effects of physical distance, face masks, and eye protection on virus transmission in healthcare and non-healthcare (eg, community) settings Click Here:
Age-dependent effects in the transmission and control of COVID-19 epidemics
The COVID-19 pandemic has shown a markedly low proportion of cases among children1-4 . Age disparities in observed cases could be explained by children having lower susceptibility to infection, lower propensity to show clinical symptoms or both. We evaluate these possibilities by fitting an age-structured mathematical model to epidemic data from China, Italy, Japan, Singapore, Canada, and South Korea. We estimate that susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12-31%) of infections in 10- to 19-year-olds, rising to 69% (57-82%) of infections in people aged over 70 years. Click Here:
Vaccines and treatment of COVID-19
There is a large global effort to develop vaccines for protection against COVID-19 and at least ten vaccine candidates have, as of early June 2020 entered clinical trials, including phase II trials . Safety and immunogenicity data have been reported in the scientific literature for the first-in-human trial assessing a vector-based SARS-CoV-2 vaccine candidate conducted in China and merit further studies . The European Medicines Agency (EMA) has been in discussion with developers of 33 potential SARS-CoV-2 vaccines since May 26, 2020. However, the EMA expects that it may take at least one year before a vaccine is approved and available for widespread use in the EU/EEA . The opportunities and challenges of developing vaccines against COVID-19 are discussed widely [266,267] and important lessons from SARS-CoV-1 vaccine development may guide SARS-CoV-2 vaccine design, testing, and implementation .
Ireland joins WHO trial comparing unproven Covid-19 treatment options
Ireland to start recruiting immediately patients at hospitals countrywide for the WHO Solidarity Trial. An agreement on behalf of the Government to enable Ireland’s participation in the World Health Organization (WHO) Covid-19 Solidarity Trial has been signed, with Government funding of €2.4 million approved. Recruitment is starting at hospitals around the country immediately. The trial is to run until March 2021.As of yesterday (Wednesday, July 1), nearly 5,500 patients had been recruited in 21 countries among the 39 countries that have approvals to begin recruiting. Overall, over 100 countries in all six WHO regions have joined or expressed an interest in joining the trial. The designated Lead Investigator for the Solidarity Trial in Ireland is Prof Joe Eustace, Director of the Clinical Research Facility in Cork, and Chair of the Senior Management Team of Health Research Board (HRB)-Clinical research Coordination Ireland.
The list of intended participating hospitals and associated clinical research facilities (CRFs) are as follows: Beaumont Hospital (RCSI Clinical Research Centre [CRC]); Our Lady of Lourdes Drogheda Hospital (RCSI CRC); Mater Misericordiae University Hospital (UCD CRC), St Vincent’s University Hospital (UCD CRC); Cork University Hospital (HRB CRF-Cork), Mercy University Hospital HRB (CRF-Cork); St James’s Hospital (Wellcome Trust HRB CRF SJH); Tallaght University Hospital (Wellcome Trust HRB CRF SJH); University Hospital Galway (HRB CRF-Galway) and University Hospital Limerick (Health Research Institute-Clinical Research Support Unit, Limerick).Initially, four treatment options had been selected for the “Solidarity” clinical study: remdesivir; lopinavir/ritonavir; lopinavir/ritonavir with interferon beta-1a; and chloroquine or hydroxychloroquine. Two weeks ago, the WHO announced that the hydroxychloroquine arm of the Solidarity Trial to find an effective Covid-19 treatment was being stopped.
The trial’s Executive Group and principal investigators made the decision based on evidence from the Solidarity trial, UK’s Recovery trial and a Cochrane review of other evidence on hydroxychloroquine. According to the WHO, Remdesivir was previously tested as an Ebola treatment. It had generated promising results in animal studies for Middle East respiratory syndrome (MERS-CoV) and severe acute respiratory syndrome (SARS), which were also caused by coronaviruses, suggesting it might have some effect in patients with Covid-19.Lopinavir/ritonavir was a licensed treatment for human immunodeficiency virus (HIV). Evidence for Covid-19, MERS and SARS was yet to show it could improve clinical outcomes or prevent infection, added the WHO. Interferon beta-1a was used to treat multiple sclerosis. Then An Taoiseach Dr Leo Varadkar, told the Dáil in May that the Department of Health was supporting the WHO Solidarity Trial, which was comparing treatment options, including remdesivir, which was available to Irish patients under certain circumstances. “By recruiting patients in several countries and shortly here too, this trial aims to rapidly assess the impacts of these treatments in slowing the disease or in improving outcomes,” Dr Varadkar told the House
Irish Medical times 2nd July https://www.imt.ie/uncategorised/ireland-joins-trial-comparing-unproven-covid-19-treatment-options-02-07-2020/
Reproduction Number Update
An Taoiseach gave an update on Primetime this week on the reduction in Covid-19 numbers as we have proceeded with the easing of restrictions in phase1, 2 and soon phase 3 . The Covid-19 positivity rate has reduced from 20% to 0.5%. If there is a second wave of Covid-19 cases with potential local outbreaks and they may be a requirement for localised lockdowns Click Here:
Warning to 15-34 age group
Dr Holohan, Chief Medial Officer has issued a warning for the under 35’s to abide to the Covid-19 guidelines to prevent the spread of the virus. . This update is due to the fact that one-third of newly confirmed cases is among the under 35s.”This is not a disease that solely affects older people”
Minister for Health Simon Harris Update 25th June
The Minister has reported a further drop in patients with #Covid19 in hospitals this morning -9 patients now in ICU and 31 patients in hospital with the virus (it was 37 yesterday)
Covid-19 Data Hib Update on Case Numbers
Breakdown of HealthCare workers with Covid-19
There is a 3 to 4% positive rate amongst health care workers.
HSE Advice to Healthcare Staff
All staff in hospitals must lead by example. When not treating patients please practice physical distancing at meetings, in the coffee shop and on ward rounds
Article Summer sun could kill coronavirus in just 30 minutes, new study shows
SARAH KNAPTON Irish Independent
During peak sunshine at the latitude of cities such as Cork – which occurs during the summer solstice around June 21 – just 30 minutes of sunlight is enough to reduce the infectivity of coronavirus by 90pc.
It means that even if someone was infected and coughed or sneezed onto an outdoor surface, the virus would be largely harmless within half an hour, with just a tiny viral load remaining.
The effect of sunlight on the virus is far greater at this time of the year. During the autumn equinox, on September 22, it would take an hour and 17 minutes to render the virus largely harmless in places such as Cork or London, and at the spring equinox, March 20, nearly three hours. At the December 21 winter solstice, the virus could survive for more than five hours in the weak sunlight, although indoors it is likely to last for days.
For cities at a more northerly latitude, such as Belfast, it would take slightly longer for disinfection – around 34 minutes in midsummer, an hour and 40 minutes in the autumn, nearly four hours in spring and more than five in winter. In the journal ‘Photochemistry and Photobiology’, Dr Jose-Luis Sagripanti and Dr David Lytle, the study report authors, wrote: “Forcing people to remain indoors may have increased contagion among same household dwellers and among patients and personnel inside the same hospital or geriatric facilities.
“In contrast, healthy people outdoors receiving sunlight could have been exposed to a lower viral dose with more chances for mounting an efficient immune response.
“The viral persistence estimated here for cities at northern latitudes where Covid-19 expanded rapidly during winter 2019-2020 and relatively higher viral inactivation in more southern latitudes receiving high solar radiation suggests an environmental role for sunlight in the pandemic.”
Sunlight includes ultraviolet radiation that damages viruses’ DNA. They have a fatty protective coating which degrades when it is warm. While the melting of the coating allows the virus to invade the warmth of the body, it dies if the casing disintegrates outside. A study by the US National Biodefence Analysis and Countermeasures Centre also found that coronavirus floating in the air decays by 90pc in just six minutes of summer sunshine and 19 minutes of winter sunlight. During the Spanish Flu pandemic of 1918, doctors found that patients who were nursed outdoors fared better than those indoors.
Irish Independent 23rd June
Article Scars of Covid-19 could last for life, say doctors amid fears of damage to brain, lungs
One in three patients who recovers from Covid-19 could be harmed for life, with long-term damage to their lungs, as well as chronic fatigue and psychological disturbances, research suggests.
Experts say there is growing evidence that the virus could cause persistent or even permanent trauma, including impairment to the brain and an increased risk of Alzheimer’s disease.
In Britain, NHS guidance suggests that around 30pc of patients who recover from Covid-19 may be left with damaged and scarred lung tissue, if it follows patterns of similar diseases.
In an interview with ‘The Daily Telegraph’, the head of the new NHS centre for Covid-19 recovery said she was worried about how little was known about how long the consequences could last.
Dr Hilary Floyd, clinical director at the NHS Seacole Centre in Surrey, said she had been shocked by how young many of its patients were. Healthy people in their 40s and 50s when the virus struck were now facing long-term fatigue and disability.
She said: “These are people who were independent, they might be running their own business, going to the gym, swimming, active – now they are at the point where they can’t get out of bed.
“We have a couple of patients in their 40s at the moment; we really didn’t expect that. We were expecting them to be older, we have seen a lot in their 50s and 60s, who are really struggling, particularly because their expectation of getting back to normal is much greater.
“They may always have some level of debilitation,” she warned.
The NHS guidance for GPs and community services warns that up to half of patients treated in intensive-care units in Britain for the virus may be left with “persistent physical, cognitive and psychological impairments” including chronic fatigue.
One in 10 of those discharged from hospitals in England after treatment for Covid-19 had been left with acute heart injury, it said. Last month, the NHS opened its first hospital dedicated to helping Covid-19 patients recover from the long-term effects. Its clinical director said loss of mobility and chronic fatigue were two of the most common problems seen in patients who had come through Covid-19, with physiotherapy one of the main treatments for recovery. In many cases, fatigue and breathlessness were so severe that patients were able to do only 10 minutes of activity at a time, Dr Floyd said.
Many patients were also struggling to cope with the psychological impact from the changes to their health, she said. “There is a lot of anxiety.” For clinicians, the most frightening aspect is that so little is known about the long-term consequences of the virus.
“I think what is worrying is that there is so much we just don’t know,” Dr Floyd said. “We don’t know how long-term ‘long-term’ is. We don’t know if the generation who is in their 50s and 60s now will be much more frail or have an increased risk of dementia in 20 years’ time.”
Prof Peter Openshaw, who sits on the UK government’s New and Emerging Respiratory Virus Threats Advisory Group (NerveTag), said: “We are quite alarmed about the number of people needing follow-up treatment after being hospitalised. Many are suffering quite prolonged effects, particularly those who had severe disease.”
He said that intensive care patients would normally take about a year to get back to full health, while some never do. Prof Openshaw, an immunologist at Imperial College London, said there was particular concern about patients who suffer extensive blood clots, which can cut off blood supply to parts of the lungs, leading to a slow recovery.
Independent 23rd June 2020
HSE SCOPI Study : COVID-19 antibody research project
The main aim of this study is to find out how widely the coronavirus has spread in Ireland and what age groups are affected. Because coronavirus is a new virus there are many things, we don’t know about it. We have been testing people who are ill, and we have been counting the number of people infected. But we don’t know how many people may have either:
- had the virus but were never tested
- only had a mild illness or no symptoms and did not know they had the virus
The study will help us to better understand the spread of coronavirus and what we need to do to control it. It will help to decide on vaccination programmes, when a vaccine becomes available.
Further Information Click Here:
Covid -19 Data Hub
Irelands new Covid-19 dashboard which gives up to date analytics of the number of cases, number of Covid-19 deaths , number of hospital admissions and ICU admission and the median ages of Covid positive cases
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NICE evidence standards framework for COVID-19 diagnostic tests,
Evidence standards framework for SARS-CoV-2 and anti-SARS-CoV-2 antibody diagnostic tests The framework This framework is a 3-stage approach to collecting the best possible data and evidence in the short and long term, while tests are being quickly developed and validated during the COVID-19 pandemic. Click Here:
NICE Remdesivir Update
Remdesivir is indicated for the treatment of adults and young people aged 12 years and over hospitalised with suspected or laboratory confirmed SARS-CoV-2 infection and severe disease. The evidence suggests some benefit with remdesivir compared with placebo for reducing supportive measures including mechanical ventilation and time to recovery in patients with mild or moderate, or severe COVID-19 disease who are on supplemental oxygen treatment.
Remdesivir is the first COVID-19 treatment to receive a positive scientific opinion by the Medicines and Healthcare products Regulatory Agency (MHRA) under the rapid early access to medicines scheme (EAMS).
Evidence standards framework for SARS-CoV-2 and anti-SARS-CoV-2 antibody diagnostic tests
Guidance for Vulnerable Groups
Guidance on cocooning to protect people over 70 years and those extremely medically vulnerable from COVID-19
This guidance is for people over 70 years of age, those who are at very high risk of severe illness from coronavirus (COVID-19) because of an underlying health condition, and for their family, friends and carers. Click Here:
HSE asks 5,000 people to take part in Covid-19 antibody study
Initial results expected in late August to measure prevalence of virus in population
The seroprevalence study, which will measure exposure to the virus using an antibody blood test, involves a representative sample of people from areas with higher and lower levels of infection.
So far, the only testing that has been done in Ireland has been to determine if a person is infected with the virus.
While the presence of antibodies afford some protection, it does not guarantee immunity.
Initial results are expected in late August and will enable the HSE’s Health Protection Surveillance Centre (HPSC) estimate the prevalence of infection of Covid-19 in the population across different age groups.
The HSE noted the presence of antibodies indicated that a person was infected with the COVID-19 virus, irrespective of whether the individual had severe or mild disease, or even asymptomatic infection.
HSeLanD Webinar Series – 22nd / 24th / 26th June 2020
Covid-19 and the requirement to socially distance has created a need to reconsider how training is delivered.
This series of three webinars is designed to provide best practice guidance and advice to help you move to a blended learning model of delivery.
Who is it for?
This programme is for anyone who is facing the challenge of moving their learning out of the classroom, including:
Educators – who want to develop their understanding of the digital
delivery options available through HSeLanD and how to best use these
options to transform a classroom course into an effective blended
Facilitators – who wish to adapt their skillset to make the most of
the different digital options to facilitate, manage and report on
their training sessions.
Managers and commissioners – who wish to understand the
possibilities, additional considerations and how to avoid potential
pitfalls when moving to a more blended solution.
What is involved?
Three highly practical 1-hour webinars based on international based practice in digital learning design.
Webinar 1 – How to design blended learning programmes Monday 22 June – 12.00 to 13.00
How to audit your current training to prepare for the digital
learning transformation Exploring the digital learning options available for designing,
facilitating and managing learning online
Selecting the most appropriate digital learning options to achieve
Register for Webinar 1 now: Click Here:
Webinar 2 – How to develop content to inspire and motivate your learners Wednesday 24 June – 12.00 to 13.00
How to create an integrated learning pathway of created & curated
content using internal and external tools
Using creative online teaching techniques for action learning,
problem-based learning and work-based learning
Designing assessment and evaluation into your digital programme
Register for Webinar 2 now: Click Here:
Webinar 3 – How to deliver Virtual Classroom sessions (not specific to one
tool) Friday 26 June – 12.00 to 13.00
Planning your virtual classroom session or series – setup, equipment, motivating and preparing your learners for the teaching session
Designing interactive content using visual aids, polls & quizzes,
breakout sessions and managing Q&A
Using a variety of delivery techniques to engage the group
Register for Webinar 3 now: Click Here:
The above webinar recordings will be made available within the Share Centre on HSELAND in due course.
Government responses should focus on detecting and isolating infected people with symptoms, the World Health Organization said. Preliminary evidence from the earliest outbreaks indicated the virus could spread even if people didn’t have symptoms. But the WHO says that while asymptomatic spread can occur, it is “very rare.”
Johnson & Johnson said yesterday it would bring forward by two months human trials of its potential Covid-19 vaccine to the second half of July, as the drug maker rushes to develop a shot for the contagious respiratory disease. The company has already signed deals with the US government to create enough manufacturing capacity to produce more than one billion doses of its vaccine through 2021, even before it has evidence that it works. There are no approved treatments or vaccines for Covid-19.Johnson & Johnson’s study will test the vaccine against a placebo and assess its safety and immune response in 1,045 healthy people aged 18-55 years, as well as those 65 years and older. The trial will take place in the US and Belgium. “Based on the strength of the preclinical data we have seen so far and interactions with the regulatory authorities, we have been able to further accelerate the clinical development,” said Johnson & Johnson’s chief scientific officer Paul Stiffest company is also in talks with the National Institutes of Allergy and Infectious Diseases to start larger, late-stage trials ahead of schedule, depending on results of the early studies and regulatory approval. Moderna Inc is at the forefront of Covid-19 vaccine development and has started testing its candidate in a mid-stage trial that will enrol 600 patients. The company expects to begin late-stage trials in July. Moderna’s vaccine uses messenger RNA technology, an approach that has not yet been approved for any medicine, while Johnson & Johnson is utilising the same technology used to make its Ebola shot. There are about 10 coronavirus vaccines in human testing and experts have predicted that a safe and effective vaccine could take 12 to 18 months from the start of development. [Irish Independent 11th June]
NPHET Blood sampling to check % of population Covid-19 positive
Thousands of people in Sligo and Dublin will be chosen to be the first groups in the country to provide blood samples to find out if they were infected with Covid-19.The National Public Health Emergency Team picked the two counties for the first prevalence survey to try to measure what percentage of the population have had the infection. Dublin was chosen because it has suffered the highest number of infections in the country, reaching 12,163 – nearly one in two of all cases so far. Sligo has just recorded 128 cases, according to the latest figures from the Health Protection Surveillance Centre. The aim was to get a region badly affected and another which had low levels of infection. The blood test will look for antibodies which are produced after a person who has had the infection has recovered. The study is planned for this month and it is expected to involve a communications campaign to get a high participation. The findings will indicate the level of immunity to the virus in the country, although it is still unclear how long this lasts due to it being a new virus. Similar studies have been carried out in other countries and were seen as important in exiting lockdown. [Irish Independent 11th June]
Patient Tracking System A young man from Ballyduff, Kilmeaden is one of the co-founders of a company that has developed a patient-tracking system to help hospitals and organisations in their bid to tackle Covid-19.
VitalTalk has developed a communication play guide that’s available in a number of languages to help healthcare professionals communicate with patients . Please see some information here about VitalTalk. VitalTalk is based in Seattle . We’ve crowdsourced this playbook to provide some practical advice on how to talk about some difficult topics related to COVID-19. Building on our experience studying and teaching communication for two decades, we’ve drawn on our networks to crowdsource the challenges and match them with advice from some of the best clinicians we know. If you know our work, you’ll recognize some familiar themes and also find new material Click Here:
Health workers should get the flu vaccination, warns Varadkar
TAOISEACH Leo Varadkar has warned the low take-up of the flu vaccine among health workers is “not on” and “has to change”. It comes amid fears that there could be a second wave of coronavirus outbreaks during the winter flu season. Mr Varadkar said such a scenario would be “very difficult” and the Government is stepping up the annual flu vaccine programme as a result, including expanding free vaccination for children. He also said efforts are being made to get health workers to be vaccinated.
Health workers should get the flu vaccination, warns Varadkar
TAOISEACH Leo Varadkar has warned the low take-up of the flu vaccine among health workers is “not on” and “has to change”. It comes amid fears that there could be a second wave of coronavirus outbreaks during the winter flu season. Mr Varadkar said such a scenario would be “very difficult” and the Government is stepping up the annual flu vaccine programme as a result, including expanding free vaccination for children. He also said efforts are being made to get health workers to be vaccinated.
Reproduction Number Update
Minister for Health Simon Harris has revealed there has been a “slight potential increase” in the Covid-19 reproductive rate.
The Minister spoke in the Dail today and said that data suggests that the reproductive number of the virus in Ireland is now between 0.4 and 0.7
HSE Comparison between Hay fever and Covid-19 Symptoms
The pollen count is higher now so more people will experience hay fever. If you normally get it, you will be familiar with the typical signs and symptoms of hay fever. They usually happen at the same time every year. While there are some similarities between the symptoms of coronavirus and hay fever, there are also ways to tell the difference.
Hay fever symptoms get worse when you are exposed to certain triggers. For example, pollen, weeds or grass. Hay fever does not cause a high temperature and most people with hay fever do not feel unwell. While coronavirus can cause symptoms in your upper airways such as loss of smell or a blocked nose, it is usually associated with a high temperature, aches and pains and a cough. Talk to your GP if you have severe or persistent symptoms. Click Here:
The National Public Health Emergency Team (NPHET) has agreed to add new symptoms to the case definition of COVID-19 in Ireland.
The new symptoms include the sudden loss of taste and smell, and GPs are set to be advised to refer to the amended case definition in identifying coronavirus cases from next week.
Social Distancing Guidelines
Leo Varadkar has said there’s a “good chance” the two metre social distancing rule can be reduced to one, if the spread of coronavirus continues to drop
Resources for Parents Gov.ie
During the COVID-19 public health emergency, parents are managing a range of new challenges.
There are many useful supports available from information and advice to one-one support however, parents are busy and there is an overwhelming amount of information available.
Parents Centre provides a starting point to access high-quality, trusted information and support. It is easy to navigate and helps parents access the information and support they need quickly.
Parents Centre is updated regularly as new resources become available Click Here:
COVID-19 Testing and Tracing Roadmap to enhance capacity and turnaround
A rapid review was commissioned by HSE leadership on 15th April 2020 to analyse the end-to-end testing infrastructure for COVID-19 and to outline initiatives to improve its performance. It was concluded on 24th April 2020 for consideration by HSE Leadership, the HSE Board, the Department of Health, Cabinet and NPHET. The paper presents a view of the target performance levels needed at each stage of the process to effectively deliver a testing pathway that will consistently and sustainably deliver increased capacity levels and reduced turnaround times while mitigating the associated risks. The stages of the review undertaken include GP referral, community swabbing, laboratory testing and contact tracing process. The paper also outlines a summary of the primary risks and constraints. The document also outlines progress to date on all actions outlined in the original paper. The HSE recognises that the availability of widespread, responsive testing with a short turnaround time is critical to the public health response to the COVID-19 pandemic
HSE Testing and Contact Tracing Dashboard 18th May
This shows an update of the numbers of aces and where they have occurred.
ECDC Covid-19 surveillance Report
The link below provides a summary from the ECDC based on data available on 21 st May 2020, 29 out of 31 countries (EU/EEA countries and the UK) showed consistently decreasing trends in COVID-19 14-day case notification rates compared to peaks that were observed 14–50 days earlier.
Dementia Understand Together
This document was developed by Family Carers Ireland in response to the Covid-19 outbreak at the request of our members but it can be used for any emergency. If you would like to share your experience of completing this document or using this plan, we would love to hear from you. If there is additional information you would like to see included in future versions please contact us by email at firstname.lastname@example.org
Society of Radiographers SoR
What action is needed to restart breast screening equipment unused during the pandemic?
Breast screening services are being reminded to consult advice about the care and maintenance of mammography x-ray equipment and trailers which has not been used during the pandemic
Society of Radiographers SoR
Screening restart: Guidance for safe service provision during Covid-19 pandemic and post pandemic phase
The Society and College of Radiographers (SCoR), in collaboration with the Royal College of Radiologists (RCR), has produced this joint guidance to support the restarting of screening services involving imaging during the COVID-19 pandemic. This document offers guidance to members and providers. It supports ‘paused’ or ‘stopped’ services to recommence safely, protecting staff and clients.
NICE COVID-19 rapid guideline: children and young people who are immunocompromised
The purpose of this guideline is to maximise the safety of children and young people who are immunocompromised during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources.
Covid-19 Case Update Ireland
RTE News 30.04.2020 :The breakdown of Covid-19 Cases
Health care Staff = 5,684
Hospitalised = 2709
Clusters = 630
ICU = 360
Remdesivir: The Covid-19 drug helping patients recover faster
An interesting update on Remdesivir trails .
The Nursing Journal – protect your family from Covid-19
This is a short 3-minute video with helpful tips to protect your family from Covid-19 .It’s very direct but has very valid points
Medical workers are worried sick, that they will get infected at work and bring the virus back home and infect their families. So, because of this, many of the medical workers isolation. But this is not really an option for everyone. There are a lot of health workers who are still living with their family, with their kids and with their room mates. So, we came up with the most basic ways for you to minimise the risk of infecting your home and your family Click Here:
The Nursing Journal Tips for Nurses Living Away from Their Families During COVID-19
This is another short video with helpful tips for those healthcare professionals who may have to move put from their family during Covid-19 to protect their family . Living in solitary is hard, especially when you don’t know when you can hug your loved ones again. If you are feeling depressed, anxious or lonely, you should know that you are not alone. Taking care of your mental health is crucial when living in isolation, so The Nursing Journal has come up with 5 ways that will help you survive self-isolation. Click Here:
GE Webinar on demand
Diagnosis and treatment of COVID-19: webinar replay available Click Here:
Memberwise 12 May @ 11:00 am – 12:00 pm
Transitioning to Online AGMs & Conferences: Your Recipe for Success
For many associations, the AGM is a constitutional requirement. But with the COVID-19 pandemic causing such widespread upheaval to all aspects of daily life, this is forcing governance professionals and membership boards to consider alternative options for their AGM. This session will aim to equip you with the key points of how a hybrid or virtual AGM could work for you, and how to practically run an online meeting to ensure member democracy and engagement is upheld. Importantly, it will also show you what that experience looks like from a member perspective. You’ll learn:
- How technology is supporting hybrid and virtual AGMs
- How to run and chair a virtual meeting
- How to improve the member experience, ensuring engagement
Maps of Covid-19 locations
There are two maps released by the HSE included here one showing the locations of cases in Dublin and the second map showing cases nationally the
data was released by the HSE late on Wednesday evening, and it accounts for all confirmed cases up to April 13 Click Here:
UCD College of Social Sciences and Law
Ireland’s COVID19 Crisis Response: Perspectives from Social Science
Join UCD Geary Institute this Friday online as they anticipate likely challenges ahead and how research can contribute to finding solutions .The first case of Covid-19 was observed in Ireland on February 29th. In the past month, we have had unprecedented change in every aspect of Irish society. The response to the pandemic progressed from warnings to school and pub closures, to a comprehensive shut down of non-essential workplaces, and strong guidelines on physical distancing, hygiene, and travel.
It is urgent to understand how people are responding to these changes. Adherence to physical distancing and protective health behaviours may be vital in delaying the transmission of the virus and allowing the health system to adapt. Understanding how to promote such adherence is a key topic of research for our community. Understanding the short-run impacts on mental and physical health is a key priority, as is understanding how the impacts of the restrictions are spread across groups of people and different types of businesses.
In the longer term, the Covid-19 pandemic will leave a wide range of public policy challenges in its wake. It would be important to anticipate now what those challenges are likely to be and to explore how research can contribute to finding solutions. With these challenges in mind, we are launching a series of Covid19 crisis policy response events. The first will take place Friday April 17th and the second will take place Friday April 24th.
The April 17th conference will take place on-line via Zoom from 10:00 -13:00. There will be 6 sessions with 3 parallel sessions in two time slots (10:00 am to 11.20am and 11.40am to 1:00pm). These sessions will be available on demand post events. Click Here:
Explained: How Scientists Are Winning the Fight Against COVID-19
Across the world, medical scientists are working hour-by-hour to try to us get beyond our new day-to-day existence. The pandemic has sparked a global scientific response, which is moving at incredible pace Click Here:
Optimisation of Vitamin D Status in the fight against Covid-19 .
This article was sent to me by a dietician and highlights that many Irish people due to lack of sunlight are Vitamin D deficient . People with low Vitamin D levels are more susceptible to acute upper respiratory tract infection. Vitamin D supplementation may decrease the likelihood of acquiring acute respirator y tract infections and decreases the severity and duration in people who do acquire an infection. Read More:
The National HSCP Office is pleased to advise that a HSCP repository is now available in the HSCP Hub on HSELanD. This repository has been developed to support the Health and Social Care Professions to deliver services in the context of the COVID-19 pandemic. It is intended that this central repository will enable a sharing of COVID and non-COVID-related resources to reduce duplication of effort for HSCP frontline staff and managers at this time.
This development will be an iterative process with new content being added as it is received. The format may change over time in line with content requirements and user feedback.
Location of HSCP Repository on HSELanD
Once logged in to www.hseland.ie, users can access the repository in three clicks:
- Go to Hubs
- Go to Health and Social Care Professions (Hub)
- Click Resources to Support HSCP Delivering services in Context of COVID-19
*If you do not have an account, you can create an account as a staff member or ‘volunteer’.
We invite HSCP frontline staff, professional bodies and other interested parties to continue to send relevant resources to the National HSCP Office by emailing email@example.com.
The Critical Care Programme (CCP)
Critical Care Programme is a collaborative multi-professional patient-centred initiative administered by National Clinical Programmes, Clinical Strategy and Programmes Directorate, HSE, in liaison with the Joint Faculty of Intensive Care Medicine of Ireland (JFICMI) and Intensive Care Society of Ireland (ICSI).
The aim of the Critical Care Programme is to improve the survival of critically ill patients.
To achieve this, the objective of the Critical Care Programme is critical care performance improvement by strengthening critical care capability. Capability domains include- information, process mapping, capacity planning, communication and engagement, and governance and leadership.
The principal priority of the Critical Care Programme is capacity maintenance and expansion in line with its Critical Care Model. Read More:
Covid-19 HSE Clinical Guidance and Evidence
- HSE Interim Clinical Guidance to provide nationally consistent advice to the clinical community in response to the Covid-19 pandemic. This is based on best available knowledge at the time of completion, written by clinical subject matter experts (SMEs) working with the HSE. These SMEs have both expertise and experience of treating patients for the specific health conditions covered by the guidance.
- Research evidence summaries prepared by the HSE National Library Evidence team and other stakeholders (these are statements of emerging evidence and do not replace clinical judgement or guidance)
- An online facility to request additional published Covid19 evidence in relation to specific clinical questions.
The content of the site is not meant to replace clinical judgment or specialist consultation, but rather strengthen clinical management of patients and provide up-to-date and relevant guidance. The guidance is iterative in nature and will be updated as the situation changes. The process for review and updating is being developed
This site provides a national easily accessible repository of clinical guidance and latest research evidence to equip the clinical community in Ireland to respond to Covid-19. Click Here:
Coronavirus: All your questions answered Podcast with Professor Martin Cormican
It can be hard to sort fact from fiction when it comes to Covid-19. Infectious disease expert Professor Martin Cormican appeared on RTÉ’s Liveline with Joe Duffy to answer questions from worried callers.
Professor Cormican – the HSE’s Clinical Lead for Infection Control – gave detailed advice to listeners on everything from sleeping arrangements to the death of a loved one. Click Here:
New Lysis Buffer RT-PCR diagnostic testing of C-19
The COVID-19 pandemic has resulted in increased need for diagnostic testing using reverse transcriptase real-time PCR (RT-PCR). An exponential increase in demand has resulted in a shortage of numerous reagents in particular those associated with the lysis buffer required to extract the viral RNA. Herein, we describe a rapid collective effort by hospital laboratory scientists, academic researchers and the biopharma industry to generate a validated lysis buffer This will be of great help to laboratories suffering shortages of renowned “LYSIS” reagent. Read More:
Health Information Quality Authority HIQA
Evidence summary for the average length of stay in the intensive care unit for COVID-1
This communication tool kit is aimed at doctors caring for Covid-19 patients, but it provides helpful advice in an easily readable format for all health care professional Click Here:
Communication Guide for difficult conversations
This guide is intended to help and support clinicians in their difficult conversations with patients and their loved ones. Click Here
The HSE has 2 new COVID-19 resources now available to all staff:
1) Rapid Review & Evidence Summary Service
Who is this for? Healthcare staff at the front line or from national clinical programmes who have requests for rapid evidence reviews in relation to COVID-19
What type of Rapid Review can I request? For a list of requests completed and in process, please visit Click Here:
When will my request be completed? All requests are reviewed (Monday – Friday) and a response returned as soon as possible.
Where can I access this service? Go to https://hselibrary.ie/ and click on ‘Submit a Rapid Review Request’
Who is providing this service? This is provided by a team of HSE librarians together with editorial input from clinicians/health care professionals.
2) Repository of HSE Interim Clinical Guidance & Evidence
The HSE National Library Service, Research & Development and Clinical Design & Innovation have worked together to provide this extensive repository. It provides consistent advice to the clinical community in response to the Covid-19 pandemic. It is informed by best available knowledge at the time of completion, written by clinical subject matter experts (SMEs) working with the HSE. These SMEs have both expertise and experience of treating patients for the specific health conditions covered by the guidance. Access Here:
National Health Library & Knowledge Service
Contact us on firstname.lastname@example.org open with the tress of Covid-19outbreakarie-Pierre
Health Protection Surveillance Centre HPSC
This website provides latest guidance for clinical and non-clinical settings on Covid-19 . Video resources include how-to put-on PPE , decontamination of clinical rates, dealing with suspected Covid-19 cases. https://www.hpsc.ie/
DOH Department of Health Information Click Here:
on this page you can view the latest daily information on how Ireland is responding to cases of COVID-19. Information included the following useful details
- Latest Updates,
- Public Health Measures
- Health Advice
- Irelands Response to Covid-19
- Social Welfare Advice for Employers/employees/self-employed
- Updates and Information from across Government
- Government of Ireland Irelands National Action Plan in Response to Covid-19
Health and Safety Authority HSA
This document below specifies requirements to implement, maintain and improve an organisation’s ability to protect against, prepare for, respond to and recover from COVID-19 related disruptions when they arise. Click Here:
Global /National Tracking of Covid-19
This website track’s global cases and trends and is updated daily. Click Here:
The number of Irish Covid-19 cases daily is available on Health Protection Surveillance Centre (HPSC) Click Here:
What happens to my coronavirus sample in the testing lab?
Dr Brigid Lucey is a Senior Lecturer and Medical Scientist at Cork Institute of Technology. She is president of the Academy of Clinical Science and Laboratory Medicine. Dr Lucey wrote an update on the process and the people involved in Covid-19 tests in medical laboratories around Ireland Read more:
Ireland’s health service uses “patientMpower” remote monitoring solution for COVID-19 patients
Dublin-based digital health firm “patientMpower “has developed a remote monitoring solution for COVID-19 on behalf of the Irish Health Service Executive (HSE).This enables monitoring of otherwise healthy patients with mild to moderate symptoms who are in self-isolation.
The national programme is already operating across several hospitals in Ireland, including the Mater, St James’s and Beaumont Hospitals in Dublin, with others currently at the on-boarding stage. Read More: